Nostos Genomics

🔎 The primary goal of a genomic lab in diagnostics is to find answers. However, unnecessary complexities and inefficiencies from multiple analysis pipelines, can often divert valuable resources away from that goal. In our latest blog article, we explore how the introduction of secondary analysis as part of Nostos’ offering, facilitates an efficient end-to-end workflow from raw sequencing data to actionable clinical insights. A streamlined process which allows our customers to focus on finding the right answers for their cases faster! ⚡ Read more here: https://lnkd.in/evN22wSy #GenomicResearch #VariantScientists #IntegratedAnalysis #WorkflowOptimization #SecondaryAnalysis #VariantAnalysis

📅 Mark your calendars and join us for a Live demo and Q&A, with our team of experts Aina Pi Roig and Pablo Botas, showcasing and introducing you to AION - Our AI-powered variant interpretation tool. In this demo, you will: 🔹 Get to know AION and submit a case 🔹 See real-world examples of AION’s variant & disease prioritisation in action 🔹 Speak to our expert team, ask questions and find out how AION might be able to help you 📅 Date: Wednesday 6th November, 2024 🕒 Time: 11:00 am CET / 10:00 am GMT 👉 Secure your spot now: https://lnkd.in/eCyD5VHs Cannot attend? Register anyways and we'll send you a link of the recording to view at your convenience 👉 Register now: https://lnkd.in/eCyD5VHs #Genomics #VariantInterpretation #PrecisionMedicine #Bioinformatics #ClinicalGenomics #NGS

👀 A new large-scale study by the Wellcome Sanger Institute highlights the benefits of genetic diagnosis for children with severe developmental disorders. The research, part of the Deciphering Developmental Disorders (DDD) study, has already delivered life-changing answers for thousands of families, offering crucial insights into rare conditions that were previously undiagnosed. The findings demonstrate the power of genomic testing in transforming rare disease care and the importance in having a definitive molecular diagnosis.. 🧬 🔍 Learn more about the impact of this study here: https://lnkd.in/e3x-QPTi 👇 #Genomics #SangerInstitute #Diagnostics

🔎 Is your lab's variant interpretation taking too long and costing too much? Accelerate your workflow with our AI-driven variant prioritisation — the fastest way to pinpoint relevant variants in just 5-10 minutes, starting at €35 per case. 🌟 Boost Productivity: Reduce manual workload and streamline your workflow. 🌟 Enhance Accuracy: Rely on precise, reliable results for better patient outcomes. 🌟 Optimise Costs: Reduce operational costs without compromising quality Let's optimise your diagnostic workflow together. 🎉 Get in touch to learn more! https://lnkd.in/epaHR3J8

We’re thrilled to share our collaboration with the INSTITUTO CHROMOMED - A collaboration which reflects our mission at Nostos to transform genetic data into better patient outcomes. As Dr. Bary G. Bigay, MD. MSc. Scientific Director at the INSTITUTO CHROMOMED highlights: "We consider AION to be an exceptional variant interpreter, surpassing the alternatives currently available on the market. We believe this collaboration could be very beneficial and we look forward to working together” Stay tuned for more updates as we embark on this exciting journey together! 🌟 https://lnkd.in/e8xX7ZjJ #GenomicResearch #VariantScientists #VariantAnalysis #Genomics #VariantInterpretation #PrecisionMedicine #Bioinformatics #ClinicalGenomics #NGS

Does your lab face challenges with complex genetic variant interpretation? Interpreting genetic variants is a complex and resource-intensive task - Analysis methods can often be time-consuming and require numerous specialised tools, leading to potential bottlenecks in rare disease diagnostics. With AI-driven tools like AION, you can automate key steps in variant interpretation, reducing the need for manual curation, accelerating diagnoses, and improving accuracy. In our latest blog article, we explore how AI-based solutions are transforming variant interpretation pipelines, making processes more accessible for many labs. Read more here: https://lnkd.in/ef4UqjSi

👀 If you didn’t see it, we recently launched our Secondary Analysis (FASTQ to VCF) service, integrated with AION - Our AI-powered variant interpretation tool. 🔬 We asked our Product Manager Ilona Lehtinen about the new release: 👉 "Excited to launch our new secondary analysis product, completing a robust end-to-end service from sequencer to report for our clients – while also opening up new opportunities for innovation for our team with greater control over the data!" Want to discuss further directly with Ilona and find out how we could help you simplify your workflow? Arrange a call here https://lnkd.in/e7Mys86Y Check your eligibility and get access to the platform https://lnkd.in/eVkxD6dX #GenomicResearch #VariantScientists #IntegratedAnalysis #WorkflowOptimization #SecondaryAnalysis #VariantAnalysis

🎉 Streamline Your Variant Analysis Workflow 🎉 We’re excited to unveil our latest product release, now introducing our secondary analysis service integrated with AION - Our AI-powered variant interpretation tool! Our secondary analysis service reduces your requirement to invest in your own technology infrastructure and simplifies the complex variant interpretation process - providing an efficient, streamlined software solution for you 👉 From raw sequencing data to meaningful clinical insights, we’ve got you covered. 👉 A seamless solution which reduces manual steps, enabling the labs we work with to reduce diagnostic turnaround times 🔬 Ready to see the difference? Click here to discover your eligibility and get access to the platform https://lnkd.in/eNUVP9sG Want to discuss further? Arrange a call here https://lnkd.in/efnQXaZH #Genomics #SecondaryAnalysis #VariantInterpretation #PrecisionMedicine #Bioinformatics #ClinicalGenomics #NGS

It was great to attend the 15th NACG Workshop last week in Oslo. Our Co-founder and CTO Rocío Acuña Hidalgo participated in the "Bridging the gap - experiences with AI-solutions" session, where she shared the learnings from Nostos Genomics with AION (Our AI-driven variant interpretation solution) to identify novel disease-causing variants in diagnostics and research (more on this soon!). 🧬🔎📊 It was great to connect, meet so many people and learn more about the advances and challenges on the clinical implementation of genomics in the Nordic countries. A big thank you to all those that attended, and to the organisers for another excellent program! 🎉 #genomics #PrecisionMedicine #NostosGenomics #NordicAlliaceOfClinicalGenomics #NACGworkshop #NACG